Answers are grounded in this paper and cite their sources.
< 0.001). MC3T3-E1 cells were used to analyze cytocompatibility and osteogenic performance. CCK-8 assays confirmed noncytotoxicity, with cell viability reaching 92.5 ± 0.36% on 20% PEG-PCL/nHA scaffolds. Cells exhibited well-spread morphology and superior adhesion on PEG-modified surfaces. Notably, the 20% PEG-PCL/nHA scaffold promoted osteogenic differentiation, showing a significant increase in alkaline phosphatase (ALP) activity and upregulation of osteogenesis-related genes (Runx2 and Col1a1). Thus, among the compositions tested in this study, the 20% PEG-PCL/nHA composite provided a favorable balance of enhanced hydrophilicity, porosity, degradation rate, and osteogenic activity, albeit with a reduction in mechanical strength. These results suggest its promising potential as a scaffold material for bone tissue engineering.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: